Tagged with reform

Romania No one can accuse the Romanian government of being lethargic when it comes to healthcare reform. After an unprecedented seven years of zero new molecules being admitted to the state reimbursement list, the pharma industry has suddenly been subjected to a whirlwind of radical refashioning and legislatory upheaval. “The industry…

pharma The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for where the country should be in 2030, how the National Health Initiative will mean a total reconstruction of the healthcare…

Pharma “Egypt: the golden gate to Africa” – The head of the export council of medical industries reviews the remaining obstacles on the way to double the value of Egyptian exports until 2018, and explains his vision of an African Union with Egypt positioned at its center. Could you please give…

Pharma Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory advisory services. As an introduction, what were your initial aspirations starting ERS? There is a continuous progression in the market…

Pharma Eduardo Negrón-Navas, attorney-at-law, for the Puerto Rican law firm Fiddler, González & Rodríguez, discusses the firm’s long-standing service to the pharmaceutical industry and the need for both government and industry to reinvent a business model better defined for the new realities of the 21st century. What is your evaluation of…

Pharma The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private label space has allowed the company to significantly expand its pipeline of products and presence in the market. To begin,…

pharma The Vice President of Health and Medicine at Pierre and Marie Curie University (UPMC) and Director of the University’s Institute of Oncology reveals how the French social security system needs to look at how to evaluate real needs, why the patient has to become more involved in the decisionmaking process,…

Pharma The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health Minister and the private health sector to create a public health enhancement fund and how the private sector is pulling resources…

Pharma The CEO of IPASA reveals how over the last ten months the priority has been to reach out to different stakeholders, rebuilding trust with the department of health, with patients and physicians; why a National Health Insurance scheme should be established to act as a true merger between the public and private…

Pharma The Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital reveals how France is the only country in the world with universal and unlimited access to healthcare, how the oncology world in France is committed to changing the perception of cancer and why the only way to prevent…

Pharma Wanda Velez, president of the Puerto Rico Medical Association, discusses the history of the organization, which dates back to 1902. She also describes the Association’s voluntary role in contrast to the Colegio de Medicos, which by law is compulsory for all Puerto Rican physicians to join. Can you describe your…

Pharma José Luis Rodríguez, CEO of Hospital Pavia Santurce, explains how budget cuts to Puerto Rico’s healthcare system will have a dramatic impact on the country’s hospitals, and outlines how medical tourism can be promoted more to bring more patients to the island. What is your current assessment of Puerto Rico’s…